Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more
US FDA approves second indication for Skyrizi to treat adults with active psoriatic arthritis Read more
Scientists demonstrate utility of bilateral tumour model for evaluating anti-cancer T-cell responses Read more